IOGYX | RYMNX | IOGYX / RYMNX | |
Total Expense Ratio | 0.76 | 1.55 | 49% |
Annual Report Gross Expense Ratio | 0.76 | 1.58 | 48% |
Fund Existence | 6 years | 21 years | - |
Gain YTD | 52.177 | 49.162 | 106% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.82B | 115M | 2,456% |
Annual Yield % from dividends | 0.76 | 0.00 | - |
Returns for 1 year | 55.25 | 44.51 | 124% |
Returns for 3 years | 61.11 | 44.32 | 138% |
Returns for 5 years | 84.04 | 50.34 | 167% |
Returns for 10 years | N/A | 129.47 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GF | 12.01 | 0.11 | +0.92% |
NEW Germany Fund | |||
BBC | 19.76 | 0.18 | +0.91% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
FITE | 71.67 | 0.63 | +0.88% |
SPDR® S&P Kensho Future Security ETF | |||
NMCO | 10.56 | 0.06 | +0.57% |
Nuveen Municipal Credit Opportunities Fund | |||
DISV | 32.43 | -0.02 | -0.06% |
Dimensional International Sm Cp Val ETF |